PROVIDER PROFILE · NPI 1659598191
Kimberly Perez
PRESCRIBING · PART D · 2024
Total Rx claims
48
Beneficiaries
—
Total drug cost
$226K
Distinct drugs
4
Brand share
50.0%
Top prescribed drugs
Lipase/Protease/Amylase13 claims
Gabapentin12 claims
Omeprazole12 claims
Cabozantinib S-Malate11 claims
QUALITY · MIPS · 2024
Final MIPS score
84.1
Quality
65.0
Cost
69.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.38%
Group
CROSS-REFERENCE